FORA Capital’s Organon & Co OGN Stock Holding History

FORA Capital’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-18,026	Closed	-$646K	–	615
2022 Q1	$646K	Buy	+18,026	New	+$616K	0.12%	237

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

FORA Capital's OGN Position: Q2 2022 in Review

FORA Capital sold out of Organon & Co (OGN) in Q2 2022, closing a stake of 18,026 shares — an estimated $646K sold.

FORA Capital first reported a position in OGN in Q1 2022 and held it in 1 quarter. The position peaked at $646K in Q1 2022. 853 funds tracked by Wall St. Rank hold OGN as of Q2 2022.

FORA Capital reported no remaining Organon & Co position as of Q2 2022 after selling out during the quarter.
FORA Capital sold 18,026 Organon & Co shares in Q2 2022, an estimated $646K.
FORA Capital first reported a position in Organon & Co in Q1 2022 and held it in 1 quarter.
FORA Capital's Organon & Co position peaked at $646K in Q1 2022.
853 funds tracked by Wall St. Rank held Organon & Co as of Q2 2022.

Based on FORA Capital's 13F filing for Q2 2022, filed 11 Aug 2022.